← Back to blog

Compounded Tirzepatide Recall: What Users Need to Know

In late September 2026, a compounding pharmacy voluntarily recalled a batch of compounded tirzepatide injections over sterility concerns, as reported by the Boston Globe and other outlets. Tirzepatide is the active ingredient in the brand-name medications Zepbound and Mounjaro, but this recall applies to compounded versions — not the brand-name pens.

What Happened

The recall was initiated over a "lack of assurance of sterility" — meaning the products couldn't be guaranteed free of contamination, not that contamination was necessarily confirmed in every vial. Compounded medications are custom-prepared by pharmacies and are not individually reviewed by the FDA for safety and effectiveness before marketing, which is part of why sterility assurance is such a central issue.

Are You Affected?

This recall is specific to compounded tirzepatide from one pharmacy and particular lots. You are not affected if:

  • You use brand-name Zepbound or Mounjaro pens.
  • You use semaglutide (compounded or brand).

You may be affected if you use compounded tirzepatide. To check:

  1. Find your vial and locate the pharmacy name and lot number.
  2. Compare them against the official recall notice (your pharmacy should proactively notify you).
  3. If you can't tell, call your compounding pharmacy and ask directly.

What to Do

  • Stop using any vial that matches a recalled lot and contact your provider.
  • Don't simply switch to a random alternative — talk to your prescriber about a safe path (a different lot, a 503B source, or a brand-name option).
  • Report any adverse effects to your provider and to FDA MedWatch.

The Bigger Picture

This is the second compounded-GLP-1 safety story in a short window, reinforcing a theme: the compounded market varies widely in quality. If you use compounded medication, keeping a record of each vial's pharmacy and lot number makes responding to a recall quick instead of stressful.

This article summarizes public reporting for general information and is not medical advice. Content was rephrased for compliance. Follow official recall notices and your provider's guidance.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment protocol.